TechnoPhage, SA - From science to innovative biopharmaceuticals
TechnoPhage selected by UK Trade & Investment for entry as a National Champion in the European Business Awards 2013-2014 for Commercial Success, Innovation and Business Ethics.
TechnoPhage's manuscript on animal efficacy for bacteriophage cocktail for the treatment of diabetic cutaneous wounds accepted for publication.
A leading consortium of industrial partners has been awarded a grant by the Seventh Framework Program of the European Union for an innovative research and development project "TA101 GOCLIN: Clinical development of TA-101 for the treatment of rheumatoid arthritis" (#606352). The aim of this Project is to take TA101, a small domain antibody…
New patent granted to TechnoPhage/Lusomedicamenta Title: Antibacterial Phage, Phage Peptides and Methods of Use Thereof Office: United States Patent and Trademark Office Date: 22/10/2013 Patent no: US 8,563,504 B2